retatrutide effect on heart rate increase: causes, risks and evidence Substack Series 3 of 6:

The Impact of GLP-1-Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta-Analysis

However, it is crucial to understand that no GLP-1 patches are currently licensed by the MHRA in the UK

The gene therapy is specifically approved for those patients who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or repeated, serious spontaneous bleeding episodes and do not have neutralizing antibodies to the adeno-associated virus serotype Rh74var (AAVRh74var) capsid

"But when it starts to affect your health and give you additional [diagnoses], it's not worth it." Now, she's deciding whether to give Wegovy a chance or opt for bariatric surgery

Plaintiffs argue that these drugs cause gastroparesis, while the defense counters that the drugs are designed to delay gastric emptying, which is different from gastroparesis